Invention Grant
US08648060B2 Use of 3-alpha-androstanediol in combination with a 5-HT1a agonist, in the treatment of sexual dysfunction
有权
使用3-α-雄甾烷二醇与5-HT1a激动剂联合治疗性功能障碍
- Patent Title: Use of 3-alpha-androstanediol in combination with a 5-HT1a agonist, in the treatment of sexual dysfunction
- Patent Title (中): 使用3-α-雄甾烷二醇与5-HT1a激动剂联合治疗性功能障碍
-
Application No.: US12513357Application Date: 2007-11-02
-
Publication No.: US08648060B2Publication Date: 2014-02-11
- Inventor: Jan Johan Adriaan Tuiten , Johannes Martinus Maria Bloemers , Robertus Petrus Johannes De Lange
- Applicant: Jan Johan Adriaan Tuiten , Johannes Martinus Maria Bloemers , Robertus Petrus Johannes De Lange
- Applicant Address: NL Almere
- Assignee: Emotional Brain B.V.
- Current Assignee: Emotional Brain B.V.
- Current Assignee Address: NL Almere
- Agency: Morrison & Foerster LLP
- Priority: EP06076976 20061103
- International Application: PCT/NL2007/050535 WO 20071102
- International Announcement: WO2008/054215 WO 20080508
- Main IPC: A61K31/56
- IPC: A61K31/56
Abstract:
The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a 5-HT1A agonist. Optionally, said 3-alpha-androstanediol and said 5HT1a agonist are further combined with a type 5 phosphodiesterase (PDE5) inhibitor.
Public/Granted literature
Information query
